Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 36NIH 3INDUSTRY 2NETWORK 1FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Prostatic Neoplasms 7Colorectal Neoplasms 6Colonic Neoplasms 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Polycystic Ovary Syndrome 2Ovarian Neoplasms 2Leiomyoma 2Endometrial Neoplasms 2Colonic Polyps 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Adenoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Sezary Syndrome 1Pseudotumor Cerebri 1Proteinuria 1Prostate cancer, familial 1Patients With Prostate Cancer 1Patient Preference 1Patient Compliance 1Papillomavirus Infections 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Healthy 1Genital Neoplasms, Female 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Observational × Sezary Syndrome × Clear all
NCT00254332 2015-03-25

Effect of Denileukin Diftitox on Immune System in CTCL Patients

FDA Office of Orphan Products Development

Completed
10 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡